Literature DB >> 1065881

A fucose-deficient glycoprotein precursor to Rauscher leukemia virus gp69/71.

R B Naso, L J Arcement, W L Karshin, G A Jamjoom, R B Arlinghaus.   

Abstract

Rauscher leukemia virus glycoprotein gp69/71 is synthesized in virus-infected cells by way of a 90,000 dalton glycoprotein precursor, termed Pr2a+b. This precursor could be labeled with radioactive glucosamine and methionine but not with fucose; whereas gp69/71 could be detected by labeling with radioactive glucosamine, fucose, or a mixture of amino acids but seemed to be deficient in methionine relative to Pr2a+b. Pr2a+b and gp69/71, were specifically precipitated by an antiserum prepared against phosphocellulose purified Rauscher gp69/71. Other virus-specific precursors, in addition to Pr2a+b, could be precipitated by antiserum prepared against detergent disrupted virus. Neither Pr2a+b nor gp69/71 was precipitated from cell extracts by antisera to Rauscher p30. Tryptic maps of Pr2a+b and gp69/71 showed that these glycoproteins share many tryptic peptides. Pulse-chase experiments with 14C-labeled amino acids indicated that gp69/71 was not radio-labeled during the pulse-labeling period but slowly appeared during the chase incubations. Pr2a+b, however, was rapidly labeled and tended to disappear during long chases. Furthermore, two nonglycosylated viral proteins, termed p15E and p12E, are structurally related to Pr2a+b. Viral p15E and p12E contained the same methionine-containing tryptic peptide fraction as Pr2a+b as determined by ion-exchange chromatography. These results provide evidence that Pr2a+b is a precursor to gp69/71 and establish a structural and possible precursor-product relationship between Pr2a+b, p15E, and p12E.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1065881      PMCID: PMC430550          DOI: 10.1073/pnas.73.7.2326

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  15 in total

1.  Viral glycoprotein synthesis under conditions of glucosamine block in cells transformed by avian sarcoma viruses.

Authors:  L J Lewandowski; R E Smith; D P Bolognesi; M S Halpern
Journal:  Virology       Date:  1975-08       Impact factor: 3.616

2.  Comparative studies on the structural phosphoproteins of mammalian type C viruses.

Authors:  B K Pal; R M McAllister; M B Gardner; P Roy-Burman
Journal:  J Virol       Date:  1975-07       Impact factor: 5.103

3.  Chromatographic separation and antigenic analysis of proteins of the oncornaviruses. V. Identification of a new murine viral protein, p15(E).

Authors:  H Ikeda; W Hardy; E Tress; E Fleissner
Journal:  J Virol       Date:  1975-07       Impact factor: 5.103

Review 4.  Biochemical properties of oncornavirus polypeptides.

Authors:  D P Bolognesi; G Huper; R W Green; T Graf
Journal:  Biochim Biophys Acta       Date:  1974-12-31

5.  A proposed nomenclature for the virion proteins of oncogenic RNA viruses.

Authors:  J T August; D P Bolognesi; E Fleissner; R V Gilden; R C Nowinski
Journal:  Virology       Date:  1974-08       Impact factor: 3.616

6.  Structural proteins of oncogenic ribonucleic acid viruses. Interspec II, a new interspecies antigen.

Authors:  M Strand; J T August
Journal:  J Biol Chem       Date:  1973-08-25       Impact factor: 5.157

7.  Polypeptides of mammalian oncornaviruses. II Characterization of murine leukemia virus polypeptide (p 15) bearing interspecies reactivity.

Authors:  W Schafer; G Hunsmann; V Moennig; F Noranha; D P Bolognesi; R W Green; G Hüper
Journal:  Virology       Date:  1975-01       Impact factor: 3.616

8.  Purification of large amounts of murine ribonucleic acid tumor viruses produced in roller bottle cultures.

Authors:  J J Syrewicz; R B Naso; C S Wang; R B Arlinghaus
Journal:  Appl Microbiol       Date:  1972-09

9.  Specific binding of the type C viral core protein p12 with purified viral RNA.

Authors:  A Sen; C J Sherr; G J Todaro
Journal:  Cell       Date:  1976-01       Impact factor: 41.582

10.  Isolation of the major viral glycoprotein and a putative precursor from cells transformed by avian sarcoma viruses.

Authors:  M S Halpern; D P Bolognesi; L J Lewandowski
Journal:  Proc Natl Acad Sci U S A       Date:  1974-06       Impact factor: 11.205

View more
  37 in total

1.  Selective decrease in the rate of cleavage of an intracellular precursor to Rauscher leukemia virus p30 by treatment of infected cells with actinomycin D.

Authors:  G A Jamjoom; R B Naso; R B Arlinghaus
Journal:  J Virol       Date:  1976-09       Impact factor: 5.103

2.  Cell surface expression of the env gene polyprotein of dual-tropic mink cell focus-forming murine leukemia virus.

Authors:  N G Famulari; K Jelalian
Journal:  J Virol       Date:  1979-06       Impact factor: 5.103

3.  Isolation and characterization of a mouse cell line containing a defective Moloney murine leukemia virus genome.

Authors:  P Besmer; H Fan; M Paskind; D Baltimore
Journal:  J Virol       Date:  1979-03       Impact factor: 5.103

4.  Analysis of precursors to the envelope glycoproteins of avian RNA tumor viruses in chicken and quail cells.

Authors:  K Moelling; M Hayami
Journal:  J Virol       Date:  1977-06       Impact factor: 5.103

5.  A model for assembly of type-c oncornaviruses.

Authors:  D P Bolognesi; R C Montelaro; S J Sullivan
Journal:  Med Microbiol Immunol       Date:  1977       Impact factor: 3.402

6.  Common precursor for Rauscher leukemia virus gp69/71, p15(E), and p12(E).

Authors:  W L Karshin; L J Arcement; R B Naso; R B Arlinghaus
Journal:  J Virol       Date:  1977-09       Impact factor: 5.103

7.  Identification of Rauscher murine leukemia virus-specific mRNAs for the synthesis of gag- and env-gene products.

Authors:  D V Zaane; A L Gielkens; W G Hesselink; H P Bloemers
Journal:  Proc Natl Acad Sci U S A       Date:  1977-05       Impact factor: 11.205

8.  Synthesis and glycosylation of polyprotein precursors to the internal core proteins of Friend murine leukemia virus.

Authors:  L H Evans; S Dresler; D Kabat
Journal:  J Virol       Date:  1977-12       Impact factor: 5.103

9.  Inhibition of maturation of Rauscher leukemia virus by amino acid analogs.

Authors:  G A Jamjoom; V L Ng; R B Arlinghaus
Journal:  J Virol       Date:  1978-01       Impact factor: 5.103

10.  Nucleotide sequence of the 3' end of MCF 247 murine leukemia virus.

Authors:  M Kelly; C A Holland; M L Lung; S K Chattopadhyay; D R Lowy; N H Hopkins
Journal:  J Virol       Date:  1983-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.